VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Administering propofol
Approved
Small molecule
I
Iuliu Hatieganu University of Medicine and Pharmacy
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Sedation
1 trial
Actualities in Procedural Sedation: Remimazolam
Active, not recruiting
·
I
Iuliu Hatieganu University of Medicine and Pharmacy
·
Phase 4
·
NCT07362173
·
200 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Administering propofol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Administering propofol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Administering propofol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Iuliu Hatieganu University of Medicine and Pharmacy company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Approved
[1]
Company
I
Iuliu Hatieganu University of Medicine and Pharmacy
Related News